Generated by GPT-5-mini| Flutter | |
|---|---|
| Name | Flutter |
| Developer | |
| Initial release | 2017 |
| Programming language | Dart (programming language) |
| License | BSD-3-Clause |
| Operating system | Android (operating system), iOS, Windows 10, macOS, Linux |
| Website | flutter.dev |
Flutter Flutter is a software development framework for building cross-platform user interfaces for Android (operating system), iOS, Windows 10, macOS, and Linux from a single codebase using the Dart (programming language). It was created by Google and has been used to develop applications such as Google Ads (application), Alibaba Group storefronts, and components for Material Design. Flutter integrates rendering, widgets, and tooling to enable rapid UI iteration and native performance on multiple devices.
The name derives from a metaphor used in marketing and documentation by Google teams alongside terms from the Dart (programming language) ecosystem; historical communications referenced internal project names and design systems like Material Design and interfaces created for events such as Google I/O. Technical literature often distinguishes between the Flutter framework, the Flutter engine (which interfaces with Skia (graphics library)) and the Dart (programming language) runtime, and contributors include developers from Chromium (web browser project) and other Google projects. Community parlance references the Flutter SDK, Flutter plugins developed for Firebase, and package management via pub.dev.
In clinical contexts, "flutter" denotes rapid repetitive physiological activity and is applied to multiple phenomena across specialties. Terminology appears in cardiology texts describing atrial rhythm disorders discussed alongside American Heart Association guidelines, in obstetrics literature concerning uterine activity in texts from institutions like Royal College of Obstetricians and Gynaecologists, and in neurology or otolaryngology sources when describing tremulous movements referenced in publications from World Health Organization or regional health agencies. Clinical practice guidelines from organizations such as European Society of Cardiology and trial reports in journals affiliated with National Institutes of Health often delineate flutter syndromes and their management.
In obstetrics and gynecology, flutter can describe rapid, repetitive uterine contractions or myometrial activity recorded during monitoring used by professionals from institutions such as Royal College of Obstetricians and Gynaecologists, American College of Obstetricians and Gynecologists, and research groups at Johns Hopkins Medicine. Uterine flutter may be discussed in perinatal surveillance literature published by World Health Organization and in textbooks produced by Oxford University Press and Elsevier; differential diagnosis includes conditions investigated by departments at Mayo Clinic and Cleveland Clinic. Management protocols often reference clinical pathways developed with input from National Health Service (England) perinatal units and maternal-fetal medicine specialists affiliated with University of California, San Francisco.
Atrial flutter is a supraventricular tachyarrhythmia described in cardiology guidelines from the European Society of Cardiology, American Heart Association, and societies such as the Heart Rhythm Society. Classic typical atrial flutter involves a reentrant circuit in the right atrium described in electrophysiology textbooks and monographs from institutions like Johns Hopkins Hospital and Mayo Clinic. Atrial flutter appears in clinical trials and cohort studies published in journals associated with National Institutes of Health and discussed at meetings convened by organizations such as the American College of Cardiology. Risk stratification tools and anticoagulation strategies reference landmark studies and recommendations from bodies including the American Heart Association and European Society of Cardiology.
Diagnosis commonly relies on electrocardiography performed according to standards from American Heart Association and equipment by manufacturers like GE Healthcare and Philips Healthcare. Investigations include ambulatory monitoring modalities produced by companies linked to Medtronic and diagnostic imaging techniques from providers such as Siemens Healthineers; invasive electrophysiological studies are performed in centers affiliated with Cleveland Clinic and Mayo Clinic. Laboratory assessment and stroke risk evaluation reference scoring systems discussed in consensus documents from European Society of Cardiology and American Heart Association, while obstetric monitoring protocols align with guidance from Royal College of Obstetricians and Gynaecologists and perinatal research at King's College London.
Management strategies follow guidelines published by the European Society of Cardiology, American Heart Association, and the Heart Rhythm Society and include rate control, rhythm control, anticoagulation, catheter ablation, and device therapy available from vendors such as Abbott (company) and Medtronic. Catheter ablation techniques originate from electrophysiology research at centers like Mayo Clinic and Cleveland Clinic and are discussed in consensus statements endorsed by the Heart Rhythm Society. Anticoagulation choices reference trials and approvals involving agencies such as the U.S. Food and Drug Administration and studies conducted by academic consortia including National Institutes of Health. Obstetric management involves multidisciplinary teams in units overseen by National Health Service (England) and specialty guidance from Royal College of Obstetricians and Gynaecologists.
Category:Medical conditions